Sanchong, Taiwan

Yi-Chun Yeh


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 23(Granted Patents)


Location History:

  • Sanchong, TW (2007 - 2011)
  • Hsin-Chu, TW (2011)
  • Taipei, TW (2009 - 2017)

Company Filing History:


Years Active: 2007-2017

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Yi-Chun Yeh in Virus-Like Particle Technology

Introduction

Yi-Chun Yeh, an accomplished inventor based in Sanchong, Taiwan, has made significant contributions to the field of biomedicine. With a total of 8 patents to his name, his work primarily focuses on the development of high-yield transgenic mammalian expression systems. Yeh’s innovations are particularly notable in the area of virus-like particles (VLPs), which play a critical role in vaccine development and therapeutic strategies.

Latest Patents

Yi-Chun Yeh’s latest patents revolve around a groundbreaking high-yield transgenic mammalian expression system for generating virus-like particles. These VLPs, derived from mammalian-hosted viruses such as SARS-CoV and influenza viruses, have been successfully produced from Vero cells. The VLPs are designed to closely resemble authentic virus particles, making them highly immunogenic. This characteristic allows them to elicit both humoral and cellular immune responses in mammals. Yeh's patents detail the compositions and methods associated with these VLPs, showcasing his innovative approach to advancing vaccine technology.

Career Highlights

Throughout his career, Yi-Chun Yeh has collaborated with prestigious organizations like AU Optronics Corporation and Academia Sinica. His tenure at these institutions has allowed him to refine his research skills and contribute to cutting-edge projects within the field of virology and immunology. Yeh's expertise in developing transgenic systems has positioned him as a prominent figure in biomedical research.

Collaborations

In his journey as an innovator, Yi-Chun Yeh has had the opportunity to work alongside esteemed colleagues, including Chia-Hung Sun and Chin-Der Wey. These collaborations have fostered a rich exchange of ideas and techniques, enhancing the overall impact of their collective research efforts. The synergies from these partnerships have undoubtedly propelled Yeh’s innovations into the forefront of scientific discovery.

Conclusion

In summary, Yi-Chun Yeh stands out as a leading inventor whose work in developing virus-like particle technologies holds great promise for the future of vaccine development. With a total of 8 patents highlighting his contributions, his innovations continue to influence the scientific community. Through his career, Yeh exemplifies the spirit of innovation, demonstrating how collaborative efforts and groundbreaking research can lead to significant advancements in biomedicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…